Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Intra-Cellular Therapies to Present at the 9th Annual SVB Leerink Global Healthcare Conference | ||
| By: GlobeNewswire - 18 Feb 2020 | Back to overview list |
|
NEW YORK, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 9th Annual SVB Leerink Global Healthcare Conference in New York. The presentation is scheduled for Tuesday, February 25, 2020 at 9:00 am ET. The live and archived webcast can be accessed under "Press Releases & Events" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software. About Intra-Cellular Therapies Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com. Contact: Intra-Cellular Therapies, Inc. Burns McClellan, Inc. MEDIA INQUIRIES: Ana Fullmer |
||
|
||
 | Back to overview list | |